ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,390.11
0.08%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aldeyra Therapeutics Inc (ALDX) Share Price

ALDX Aldeyra Therapeutics Inc

3.86
-0.10 (-2.53%)
08 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Aldeyra Therapeutics Inc NASDAQ:ALDX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.10 -2.53 3.86 3.70 4.11 4.00 3.85 3.91 225,632 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -37.54M -0.6374 -6.06 227.34M
 Type  Size  Price  Time  Units 
 9 1 3.96 23:48:38 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ALDX News
07/06/202421:07EDGAR2Form 8-K - Current report
06/06/202421:12EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
06/06/202421:12EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
06/06/202421:12EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
29/05/202412:00BWAldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
08/05/202412:00BWAldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
25/04/202412:00BWAldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
Period
Draw mode
Data Downloads for ALDX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Aldeyra Therapeutics Inc Articles